SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001008848-12-000044
Filing Date
2012-08-08
Accepted
2012-08-08 17:12:45
Documents
11
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q quarterly_report-063012.htm 10-Q 733495
2 CEO CERTIFICATION exhibit31_1-ceocertification.htm EX-31.1 14987
3 CFO CERTIFICATION exhibit31_2-cfocertification.htm EX-31.2 14995
4 CEO CERTIFICATION exhibit32_1-ceocertification.htm EX-32.1 6499
5 CFO CERTIFICATION exhibit32_2-cfocertification.htm EX-32.2 6460
  Complete submission text file 0001008848-12-000044.txt   5140620

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT acor-20120630.xml EX-101.INS 599671
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acor-20120630.xsd EX-101.SCH 44212
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT acor-20120630_cal.xml EX-101.CAL 54351
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT acor-20120630_def.xml EX-101.DEF 230824
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acor-20120630_lab.xml EX-101.LAB 752735
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acor-20120630_pre.xml EX-101.PRE 327755
Mailing Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50513 | Film No.: 121017625
SIC: 2836 Biological Products, (No Diagnostic Substances)